ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $301,728 | 0.0% | 90,068 | 0.0% | 0.00% | – |
| Q1 2023 | $301,728 | -30.4% | 90,068 | 0.0% | 0.00% | – |
| Q4 2022 | $433,227 | -99.9% | 90,068 | +3.0% | 0.00% | – |
| Q3 2022 | $497,578,000 | -31.0% | 87,448 | -13.9% | 0.00% | – |
| Q2 2022 | $721,260,000 | +518.6% | 101,586 | +529.1% | 0.00% | – |
| Q1 2022 | $116,596,000 | -19.2% | 16,149 | 0.0% | 0.00% | – |
| Q4 2021 | $144,372,000 | -67.4% | 16,149 | +27.9% | 0.00% | – |
| Q3 2021 | $442,668,000 | – | 12,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |